2-(Hydroxymethyl)-5-methoxypyrimidine

Catalog No.: 
ACRUAK561
CAS No.: 
1459748-95-8
Molecular Formula: 
C6H8N2O2
Molecular Weight: 
140.14
2-(Hydroxymethyl)-5-methoxypyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$57.00In stockInquiry
250mg97%$113.00In stockInquiry
1g97%$316.00In stockInquiry
5g97%$948.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Hydroxymethyl)-5-methoxypyrimidine
IUPAC Name(5-methoxypyrimidin-2-yl)methanol
MDL No.MFCD28501385
Molecular FormulaC6H8N2O2
Molecular Weight140.14
SMILESCOC1=CN=C(CO)N=C1
InChI KeyWCRPQDPGKHYFSH-UHFFFAOYSA-N
Synonym5-Methoxy-2-pyrimidinemethanol | SCHEMBL15263725 | F30447 | EN300-7214344 | (5-METHOXYPYRIMIDIN-2-YL)METHANOL | 1459748-95-8 | WCRPQDPGKHYFSH-UHFFFAOYSA-N | AKOS024195024 | 2-Pyrimidinemethanol, 5-methoxy- | CS-0183766 | SB12717 | 2-(Hydroxymethyl)-5-meth
CAS No.1459748-95-8
PubChem CID84762600

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H320-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACRUAK561 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOKZQ238 route compound structure diagram
    ACOKZQ2381415800-40-6In Stock
  2. Then
  3. ACRUAK561 route product structure diagram
    ACRUAK5611459748-95-8In Stock
Inquiry

2. ACRUAK561 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRUAK561 route product structure diagram
    ACRUAK5611459748-95-8In Stock
Inquiry

3. ACRUAK561 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRUAK561 route product structure diagram
    ACRUAK5611459748-95-8In Stock
Inquiry

Comments (0)